Sanitary product for bedpan

Abstract

To provide a sanitary product for a bedpan excellent in an effect for putting a bowl part of the bedpan into a sanitary state.SOLUTION: A pharmaceutical composition 1 for releasing a pharmaceutical component effective for sanitization of a bowl part 3 of a bedpan is installed on the bowl part 3 side of a toilet lid 2 of the bedpan. When the toilet lid 2 is closed, the pharmaceutical component released from the pharmaceutical composition 1 spreads over the bowl part 3 of the bedpan, thereby enabling effective sanitization of the bowl part. The pharmaceutical component is a volatile agent having a vapor pressure of 1×10-7 Pa or more at 25°C.SELECTED DRAWING: Figure 1

Description

[Technical Field]

[0001] The present invention relates to a toilet sanitary product for use with a toilet having an openable toilet lid. More specifically, the present invention relates to a toilet sanitary product that is attached to the bowl side of the toilet lid and releases a medicinal component into the bowl side, thereby maintaining the bowl side of the toilet in a hygienic state. [Background technology]

[0002] In homes and commercial facilities, maintaining hygienic toilets is important not only for maintaining the health of residents and users, but also for living comfortably and with a good mood.

[0003] Toilet bowl cleaners are known as one type of product for hygienic toilets (toilet bowl sanitary products). Among toilet bowl cleaners, those that are diluted with flush water for use are known as toilet bowl cleaners that can be used easily and reduce the effort required for scrubbing and other such tasks. Such toilet bowl cleaners are installed in the hand washing section, water storage tank, rim, bowl, etc. of a toilet bowl, and can be used to clean the bowl by diluting the toilet bowl cleaner in flush water and running it through the bowl. However, toilet bowl cleaners that are diluted with flush water for use can only exert their cleaning action in the areas of the bowl of the toilet bowl through which the flush water passes, and cannot be expected to have a cleaning effect in areas through which the flush water does not pass, and therefore improvement is desired.

[0004] Toilet bowl fragrances and deodorizers are also known as toilet bowl hygiene products. These fragrances and deodorizers are typically installed in toilets to provide a pleasant atmosphere within the toilet space. However, because these toilet bowl fragrances and deodorizers are installed in toilets to provide a fragrance and deodorizing effect within the toilet space, they cannot be applied directly to the toilet bowl, which is the main source of odors, and therefore have limited effectiveness. Furthermore, toilet bowl cleaners that are conventionally diluted with flush water and then formulated with fragrances and deodorizing ingredients are also known, which can then be diluted with flush water to directly provide a fragrance and deodorizing effect within the toilet bowl. However, as mentioned above, when diluted with flush water, the desired effect is not achieved in areas of the bowl that the flush water does not pass through, and only limited effectiveness can be expected.

[0005] As such, conventional toilet sanitary products have limited effectiveness in terms of sanitizing the bowl portion of a toilet, and there is a need for the development of products that are highly effective in keeping the bowl portion of a toilet hygienic. Summary of the Invention [Problem to be solved by the invention]

[0006] SUMMARY OF THE INVENTION An object of the present invention is to provide a toilet sanitary product that is highly effective in keeping the bowl of a toilet in a sanitary state. [Means for solving the problem]

[0007] The present inventors conducted extensive research to solve the above-mentioned problems and discovered that the above problems can be solved by adopting a toilet sanitary product with a completely different usage pattern from conventional toilet sanitary products. Specifically, the present inventors discovered that by placing a pharmaceutical composition that releases a pharmaceutical component effective for sanitizing the bowl of a toilet bowl on the bowl side of the toilet lid and closing the lid, the pharmaceutical component released from the pharmaceutical composition will permeate the bowl of the toilet bowl, effectively sanitizing the bowl. Furthermore, the present inventors discovered that by using a volatile pharmaceutical component, the pharmaceutical component can be released in gas form from the pharmaceutical composition, allowing the pharmaceutical component to permeate the entire surface of the bowl of the toilet bowl, the rim (including the back surface), and even the interior of the rim (the water-passing portion), thereby more effectively sanitizing the toilet. The present invention was completed through further research based on these findings.

[0008] That is, the present invention provides the following aspects. Item 1. A toilet sanitary product for use with a toilet having an openable toilet lid, a pharmaceutical composition that releases a pharmaceutical component; A toilet sanitary product that is installed on the bowl side of the toilet lid. Item 2. The toilet sanitary product according to Item 1, wherein the medicinal component is at least one selected from the group consisting of a cleaning component, an antibacterial component, a fragrance component, and a deodorizing component. Item 3. The toilet bowl sanitary product according to Item 1 or 2, wherein the medicinal component is a volatile medicinal component. Item 4. The toilet bowl sanitary product according to any one of Items 1 to 3, wherein the medicinal composition contains the medicinal component and / or a source of the medicinal component. Item 5. The toilet sanitary product according to any one of Items 1 to 4, wherein the pharmaceutical composition is contained in a container having a storage section for storing the pharmaceutical composition and a release section for releasing the pharmaceutical component from the pharmaceutical composition to the outside of the container. [Effects of the Invention]

[0009] According to the toilet sanitary product of the present invention, the chemical component that sanitizes the bowl of the toilet can be spread throughout the bowl of the toilet, thereby maintaining the toilet in a hygienic state. In particular, when a volatile chemical is used as the chemical component, the chemical component can be spread over the entire surface of the bowl of the toilet, the rim (including the back surface), and even the inside of the rim (the water-passing portion), making it possible to sanitize the toilet more effectively. [Brief explanation of the drawings]

[0010] [Figure 1] FIG. 1 is a schematic diagram showing the toilet sanitary product of the present invention installed on the bowl side of the toilet lid of a toilet (when the toilet lid is open). [Figure 2] FIG. 1 is a schematic diagram showing the toilet sanitary product of the present invention installed on the bowl side of the toilet lid of a toilet (when the toilet lid is closed). DETAILED DESCRIPTION OF THE INVENTION

[0011] The toilet sanitary product of the present invention is a toilet sanitary product for use in a toilet having an openable toilet lid, which contains a medicinal composition that releases a medicinal component and is placed on the bowl side of the toilet lid. The toilet sanitary product of the present invention will be described in detail below.

[0012] Pharmaceutical composition The toilet bowl hygiene product of the present invention includes a medicinal composition that releases medicinal ingredients to sanitize the toilet bowl.

[0013] [Drug ingredients] In the present invention, the term "medicinal component" refers to a component that can sanitize the bowl of the toilet, and specifically includes cleaning components, antibacterial components, fragrance components, deodorizing components, etc. Here, the term "antibacterial component" refers to all components that inhibit or reduce the growth of bacteria or fungi, including those with disinfecting, bacteriostatic, germicidal, and antifungal effects.

[0014] Chlorine dioxide is a suitable example of a cleaning ingredient used as a chemical ingredient. Chlorine dioxide is known to have antibacterial properties, but as shown in the test examples described below, it has also been newly discovered to have the effect of removing stains such as feces and blackheads (stain removal effect) and the effect of preventing the adhesion of such stains (anti-stain effect).

[0015] Another example of a cleansing component used as a medicinal component is a surfactant. The surfactant may be any of a nonionic surfactant, a cationic surfactant, an anionic surfactant, and an amphoteric surfactant. Specific examples of surfactants include nonionic surfactants such as polyoxyethylene hydrogenated castor oil, polyoxyethylene hydrogenated castor oil ether, polyoxyethylene alkyl ether, polyoxyethylene lauryl ether, polyoxyethylene oleyl ether, polyoxyethylene fatty acid ester, polyoxyethylene glyceryl ether fatty acid ester, alkyl alkanolamide, alkyl polyglucoside, sorbitan fatty acid ester, glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene polyoxypropylene glycol; anionic surfactants such as alkyl sulfates, polyoxyethylene alkyl ether sulfates, sulfosuccinates, N-acylamino acid salts, carboxylates, α-olefin sulfonates, and phosphate esters; cationic surfactants such as alkyl ammonium salts; and amphoteric surfactants such as alkylamidobetaine and alkyldimethylamine oxide. These surfactants may be used alone or in combination of two or more.

[0016] The antibacterial component used as the medicinal component is not particularly limited as long as it can exert an antibacterial effect on the bowl of the toilet, and examples thereof include chlorine dioxide, dichloroisocyanurate, trichloroisocyanurate, octyltrimethylammonium chloride, didecyldimethylammonium gluconate, chlorhexidine, chlorhexidine gluconate, allyl isothiocyanate, propylene glycol monomethyl ether, propylene glycol monopropyl ether, hinokitiol, benzoic acids, salicylic acids, sorbic acids, parabens, chlorhexidine chloride, chlorhexidine gluconate, isopropylmethylphenol, triclosan, lysozyme chloride, potassium iodide, etc. These antibacterial components may be used alone or in combination of two or more.

[0017] The fragrance component used as the pharmaceutical ingredient is not particularly limited as long as it can exert an aromatic effect, and may be any of natural fragrances, single fragrances isolated from natural fragrances, synthetic single fragrances, and blended fragrances thereof, and conventionally known fragrances can be used. Specifically, as the single fragrance, hydrocarbon fragrances such as d-limonene, caryophyllene, α-pinene, β-pinene, myrcene, terpinolene, ocimene, γ-terpinene, α-phellandrene, p-cymene, β-caryophyllene, β-farnesene, 1,3,5-undecatriene, and diphenylmethane can be used;Cis-3-hexenol, linalool, geraniol, phenylethyl alcohol, trans-2-hexenol, cis-3-hexenol, 3-octanol, 1-octen-3-ol, 2,6-dimethyl-2-heptanol, 9-decenol, 4-methyl-3-decen-5-ol, 10-undecenol, trans-2-cis-6-nonadiethanol, linalool, geraniol, nerol, citronellol, rhodinol, myrcenol, lavandulol, tetrahydrogeraniol, tetrahydrolin ol, hydroxycitronellol, dihydromyrcenol, allooxymenol, terpineol, α-terpineol, terpinen-4-ol, l-menthol, borneol, isopulegol, nopol, farnesol, nerolidol, cedrol, patchouli alcohol, vetiverol, 2,4-dimethyl-3-cyclohexene-1-methanol, 4-isopropylcyclohexanol, 4-isopropylcyclohexanemethanol, 1-(4-isopropylcyclohexyl)-ethanol, 2,2-di Methyl-3-(3-methylphenyl)-propanol, pt-butylcyclohexanol, ot-butylcyclohexanol, ambrinol, 1-(2-t-butylcyclohexyloxy)-2-butanol, pentamethylcyclohexylpropanol, 1-(2,2,6-trimethylcyclohexyl)-3-hexanol, benzyl alcohol, phenylethyl alcohol, phenoxyethyl alcohol, styrallyl alcohol, anise alcohol, cinnamic alcohol, phenylpropyl alcohol, diisopropyl alcohol, methylisothiazolinone ... Alcohol-based fragrances such as methylbenzyl carbinol, dimethylphenylethyl carbinol, phenylethylmethylethyl carbinol, 3-methyl-5-phenylpentanol, thymol, carvacrol, orcinol monomethyl ether, eugenol, isoeugenol, propenylguaethol, santalol, isobornylcyclohexanol, sandalore, bagdanol, sandalmysolkha, brahmanol, evanol, polysanthol, and 3,7-dimethyl-7-methoxyoctan-2-ol;Diphenyl oxide, p-cresyl ethyl ether, dl-rose oxide, (nerol oxide, myroxide, 1,8-cineole, rose oxide, rimetol, menthofuran, linalool oxide, butyldimethyldihydroxypyran, acetoxyamyltetrahydropyran, cedryl methyl ether, methoxycyclododecane, 1-methyl-1-methoxycyclododecane, ethoxymethyl cyclododecyl ether, trichlordecenyl methyl ether, Rubofix, cedroxide, ambroxan, grisalva, voisilis, anisole, dimethylhydroquinone, p-cresyl methyl ether, acetanisole, anethole, dihydroanethole, estragole, diphenyl oxide, methyleugenol Ether-based fragrances such as hexanal, citral, hexyl cinnamic aldehyde, hexyl aldehyde, octyl aldehyde, nonyl aldehyde, decyl aldehyde, undecyl aldehyde, dodecyl aldehyde, tridecyl aldehyde, trimethylhexyl aldehyde, methyl octyl acetylaldehyde, methyl nonyl acetaldehyde, trans-2-hexenal, cis-4-heptenal, 2,6-nonadienal, cis-4-decenal, trans-4-decenal, undecylenic aldehyde, trans-2-dodecenal, trimethylundecenal, 2,6,10-trimethyl-5,9-undecadiena; Alcohol, citronellal, hydroxycitronellal, perillaldehyde, methoxydihydrocitronellal, citronellyloxyacetaldehyde, 2,4-dimethyl-3-cyclohexenylcarboxaldehyde, isocyclocitral, centenal, mylac aldehyde, lyral, vernal, dupical, maceal, boronal, cetnal, benzaldehyde, phenylacetaldehyde, phenylpropylaldehyde, cinnamic aldehyde, α-amylcinnamic aldehyde, α-hexylcinnamic aldehyde, hydroxycitronellal ... Aldehyde fragrances such as drotropic aldehyde, anisaldehyde, p-methylphenylacetaldehyde, cuminaldehyde, cyclamen aldehyde, 3-(pt-butylphenyl)-propylaldehyde, p-ethyl-2,2-dimethylhydrocinnamaldehyde, 2-methyl-3-(p-methoxyphenyl)-propylaldehyde, pt-butyl-α-methylhydrocinnamic aldehyde, salicylic aldehyde, heliotropin, helional, vanillin, ethyl vanillin, and methyl vanillin; octylaldehyde glycol acetal, acetaldehyde Acetaldehyde ethyl cis-3-hexenyl acetal, citral dimethyl acetal, citral diethyl acetal, acetaldehyde ethyl linalyl acetal, acetaldehyde ethyl linalyl acetal, hydroxycitronellal dimethyl acetal, phenylacetaldehyde dimethyl acetal, hydratropic aldehyde dimethyl acetal, phenylacetaldehyde glyceryl acetal, acetaldehyde ethyl phenyl acetal, acetaldehyde phenylethyl propyl acetal, phenylpropyl aldehyde Acetal fragrances such as propylene glycol acetal, 4,4,6-trimethyl-2-benzyl-1,3-dioxane, 2,4,6-trimethyl-2-phenyl-1,3-dioxane, 2-butyl-4,4,6-trimethyl-1,3-dioxane, tetrahydroindeno-m-dioxine, dimethyltetrahydroindeno-m-dioxine, and caranal; ethyl butyrate, styrallyl acetate, ot-butyl cyclohexyl acetate, ethyl formate, cis-3-hexenyl formate, linalyl formate, citronellyl formate, geranyl formate, benzyl formate,Phenylethyl formate, ethyl acetate, butyl acetate, isoamyl acetate, methyl cyclopentylidene acetate, hexyl acetate, cis-3-hexenyl acetate, trans-3-hexenyl acetate, isononyl acetate, citronellyl acetate, lavandulyl acetate, geranyl acetate, linalyl acetate, myrcenyl acetate, terpinyl acetate, menthyl acetate, menthanyl acetate, nopyr acetate, n-bornyl acetate, isobornyl acetate, pt-butylcyclohexyl acetate, ot-butylcyclohexyl acetate, tricyclodecenyl acetate, acetic acid 2,4-Dimethyl-3-cyclohexene-1-methanil, Benzyl Acetate, Phenylethyl Acetate, Styrallyl Acetate, Cinnamyl Acetate, Anisyl Acetate, Paracresyl Acetate, Heliotropyl Acetate, Acetyleugenol, Acetylisoeugenol, Guaiyl Acetate, Cedryl Acetate, Vetiveryl Acetate, Decahydro-β-Naphthyl Acetate, Ethyl Propionate, Isoamyl Propionate, Siloneryl Propionate, Siloneryl Propionate, Propionyl Geranyl propionate, linalyl propionate, terpinyl propionate, benzyl propionate, cinnamyl propionate, allyl cyclohexylpropionate, tricyclodecenyl propionate, ethyl butyrate, ethyl 2-methylbutyrate, butyl butyrate, isoamyl butyrate, hexyl butyrate, linalyl butyrate, geranyl butyrate, citronellyl butyrate, benzyl butyrate, cis-3-hexenyl isobutyrate, citronellyl isobutyrate, geranyl isobutyrate, Linalyl isobutyrate, benzyl isobutyrate, phenylethyl isobutyrate, phenoxyethyl isobutyrate, tricyclodecenyl isobutyrate, ethyl valerate, propyl valerate, citronellyl isovalerate, geranyl isovalerate, amyl isovalerate, benzyl isovalerate, phenylethyl isovalerate, ethyl caproate, allyl caproate, ethyl enanthate, allyl enanthate, ethyl caprate, citronellyl tiglate, octyl carumbo Methyl benzoate, allyl 2-pentyloxyglycolate, cis-3-hexenylmethyl carbonate, ethyl ketoate, isoamyl pyruvate, ethyl acetate, ethyl levulinate, methyl benzoate, ethyl benzoate, isobutyl benzoate, isoamyl benzoate, geranyl benzoate, linalyl benzoate, benzyl benzoate, phenylethyl benzoate, phenylethyl benzoate, methyl dihydroxymethylbenzoate, methyl phenylacetate,Methyl phenylacetate, Ethyl phenylacetate, Isobutyl phenylacetate, Isoamyl phenylacetate, Geranyl phenylacetate, Benzyl phenylacetate, Phenylethyl phenylacetate, p-Cresyl phenylacetate, Methyl cinnamate, Ethyl cinnamate, Benzyl cinnamate, Cinamyl cinnamate, Phenylethyl cinnamate, Methyl salicylate, Ethyl salicylate, Isobutyl salicylate, Isoamyl salicylate, Hexyl salicylate, cis-3-hexenyl salicylate, Benzyl salicylate, Phenylethyl salicylate, Methyl anisate, Ethyl anisate, Methyl anthranilate Ester-based fragrances such as ethyl anthranilate, methyl methyl anthranilate, methyl jasmonate, methyl dihydrojasmonate, ethyl methylphenylglycidate, ethyl phenylglycidate, glycomel, fractone, fractone, fractone, fructose, dibescone, ethyl 2-methyl-6-pentyl-4-oxa-2-cyclohexene carbonate; 2-octanone, δ-damascone, acetoin, diacetyl, methyl amyl ketone, ethyl amyl ketone, methyl hexyl ketone, methyl nonyl ketone, methylheptenone, koabon, camphor, carbo Menthone, d-pulegone, piperitone, fenchone, geranylacetone, cedryl methyl ketone, nootkatone, ionone, α-ionone, β-ionone, methyl ionone, α-n-methylionone, β-n-methylionone, α-isoionone, β-isoionone, allylonone, irone, α-irone, β-irone, γ-irone, damascone, α-damascone, β-damascone, δ-damascone, damascenone, dynascone, α-dynascone, β-dynascone, maltol, ethyl maltol, 2,5-dimethyl-4-hydroxyfuranone Sugar lactone, pt-butylcyclohexanone, amylcyclopentanone, heptylcyclopentanone, dihydrojasmone, cis-jasmone, Florex, plicatone, 4-cyclohexyl-4-methyl-2-pentanone, p-menthen-6-ylpropanone, 2,2,5-trimethyl-5-pentylcyclopentanone, ethoxyvinyltetracyclohexanone, dihydropentamethylindanone, Iso-E-Super, Trimofix, acetophenone, p-methylacetophenone, benzyl acetone, calone, raspberry ketone,Ketone-based fragrances such as anisylacetone, 4-(4-hydroxy-3-methoxyphenyl)-2-butanone, methyl naphthyl ketone, 4-phenyl-4-methyl-2-pentanone, and benzophenone; carboxylic acid-based fragrances such as geranilic acid, citronellic acid, benzoic acid, phenylacetic acid, phenylpropionic acid, cinnamic acid, and 2-methyl-2-pentenoic acid; γ-octalactone, γ-nonalactone, γ-decalactone, γ-undecalactone, δ-decalactone, coumarin, Lactone fragrances such as dihydrocoumarin, jasmolactone, and jasmine lactone; muscone, civetone, cyclopentadecanone, cyclohexadecenone, cyclopentadecanolide, 12-ketocyclopentadecanolide, cyclohexadecanolide, cyclohexadecenolide, 12-oxa-16-hexadecanolide, 11-hexa-16-hexadecanolide, 10-oxa-16-hexadecanolide, ethylene brassile Musk fragrances such as methyl acrylate, ethylene dodecanedioate, musk ketone, musk xylol, musk ambrette, musk tibetene, musk mosquene, 6-acetylhexamethylindan, 4-acetyldimethyl-t-butylindan, 5-acetyltetramethylisopropylindan, 6-acetylhexatetralin, hexamethylhexahydrocyclopentanebenzopyran; acetylpyrrole, indole, skatole Examples include nitrogen-containing fragrances such as indolene, 2-acetylpyridine, maritimum, 6-methylquinoline, 6-isopropylquinoline, isobutylquinoline, 2-acetylpyrazine, 2,3-dimethylpyrazine, 2-isopropyl-3-methoxypyrazine, 2-isobutyl-3-methoxypyrazine, 2-secondary butyl-3-methoxypyrazine, trimethylpyrazine, and 5-methyl-3-heptane oxime; nitrile-based fragrances such as geranyl nitrile, citronellyl nitrile, 5-phenyl-2,6-nonadiene nitrile, cinnamon nitrile, cumin nitrile, dodecane nitrile, and tridecene-2-nitrile; and sulfur-containing fragrances such as dimethyl sulfide, 2-methyl-4-propyl-1,3-oxathiane, allyl isocyanate, p-menthane-8-thiol-3-one, p-menthene-8-thiol, and methyl p-menthylthiopropionate.Natural fragrances include tuberose oil, musk tincture, castoreum tincture, civet tincture, ambergris tincture, peppermint oil, perilla oil, petitgrain oil, pine oil, rose oil, rosemary oil, camphor oil, aromatic oils, clary sage oil, sandalwood oil, spearmint oil, spike lavender oil, star anise oil, lavandin oil, lavender oil, lemon oil, lemongrass oil, lime oil, neroli oil, oakmoss oil, ocotia oil, patchouli oil, and thyme oil. , tonka bean tincture, turpentine oil, crocodile bean tincture, basil oil, nutmeg oil, citronella oil, clove oil, bois rose oil, cananga oil, cardamom oil, cassia oil, cedarwood oil, orange oil, mandarin oil, tangerine oil, anise oil, bay oil, coriander oil, elemi oil, eucalyptus oil, fennel oil, galbanum oil, geranium oil, hiba oil, cypress oil, jasmine oil, vetiver oil, bergamot oil, ylang-ylang oil, grapefruit oil, yuzu oil, etc. These fragrance components may be used alone, or two or more may be combined to create a fragrance.

[0018] The deodorizing component used as the chemical component is not particularly limited as long as it can exert a deodorizing effect on the bowl of the toilet, and examples thereof include dichloroisocyanurates, trichloroisocyanurates, extracts of plants such as rice, pine, cypress, bamboo, persimmon, and tea, desalted betaine compounds, modified organic acid compounds, alkanolamines, chlorine dioxide, ozone, aldehyde compounds, glycol ether compounds, phytoncide fragrances, and lower aliphatic aldehyde fragrances. These deodorizing components may be used alone or in any combination of two or more.

[0019] These drug ingredients may be used alone or in combination of two or more.

[0020] Among these pharmaceutical components, preferred are volatile (vaporizable) pharmaceutical components. Volatile pharmaceutical components are pharmaceutical components that volatilize (vaporize) at room temperature and pressure (25°C, approximately 1 atm), and specifically, pharmaceutical components with a vapor pressure of 1 x 10 atm at 25°C.-7 This applies to chemical ingredients with a viscosity of 100 Pa or higher. When the toilet lid is closed, the volatile chemical ingredient is released in gaseous form into the space formed by the toilet lid and bowl, allowing the chemical ingredient to spread over the entire surface of the bowl, making it possible to more effectively impart the sanitizing effect of the chemical ingredient.

[0021] Specific examples of volatile chemical components include volatile cleaning components such as chlorine dioxide; fragrance components; antibacterial components such as chlorine dioxide and allyl isothiocyanate; and deodorizing components such as chlorine dioxide and ozone. These volatile chemical components may be used alone or in any combination of two or more. Among these volatile chemical components, chlorine dioxide is preferably used because it exhibits cleaning, antibacterial, and deodorizing effects and is highly effective in sanitizing the bowl of the toilet.

[0022] The composition of the pharmaceutical composition used in the present invention is not particularly limited as long as it is capable of releasing the pharmaceutical component, and may be in an embodiment containing the pharmaceutical component itself (hereinafter referred to as "pharmaceutical composition of embodiment 1"), or in an embodiment containing a source of the pharmaceutical component and designed to be able to generate the pharmaceutical component (hereinafter referred to as "pharmaceutical composition of embodiment 2").

[0023] The content of the drug component in the drug composition of Aspect 1 may be appropriately set depending on the type of drug component used, the dosage form of the drug composition, etc., and may be, for example, 0.0001 to 30% by weight, preferably 0.001 to 20% by weight, more preferably 0.01 to 20% by weight, and even more preferably 0.1 to 10% by weight.

[0024] The pharmaceutical composition of the second aspect is only required to contain a source of the pharmaceutical component and be configured to be able to generate the pharmaceutical component, and the type of pharmaceutical component used in the pharmaceutical composition of the second aspect is not particularly limited as long as it can be generated in the composition.

[0025] Chlorine dioxide is a suitable example of a pharmaceutical ingredient used in the pharmaceutical composition of Aspect 2. Hereinafter, the pharmaceutical composition of Aspect 2 using chlorine dioxide as a pharmaceutical ingredient will be referred to as a "chlorine dioxide-generating composition," and its composition and other aspects will be described.

[0026] (Composition of chlorine dioxide generating composition, etc.) Chlorine dioxide is generated by the reaction of a chlorite with an acid in the presence of water, so the chlorine dioxide generating composition only needs to contain a chlorite and an acid as a source of chlorine dioxide.

[0027] The type of chlorite used as one component of the chlorine dioxide generation source is not particularly limited, and examples thereof include alkali metal salts of chloric acid such as lithium chlorite, sodium chlorite, and potassium chlorite; alkaline earth metal salts of chloric acid such as calcium chlorite, magnesium chlorite, and barium chlorite; etc. These chlorites may be used alone or in combination of two or more.

[0028] The content of chlorite in the chlorine dioxide generating composition may be appropriately set depending on the shape of the pharmaceutical composition of Aspect 2, the mode of chlorine dioxide release, the installation site, etc., and may be, for example, 0.1 to 30% by weight, preferably 1 to 10% by weight.

[0029] The type of acid used as one component of the chlorine dioxide generation source is not particularly limited, as long as it is acidic when dissolved in water and can generate chlorine oxide from chlorite in the presence of water. Examples of the acid include phosphoric acid, potassium dihydrogen phosphate, sodium dihydrogen phosphate, sodium sulfite, potassium sulfite, sodium pyrosulfite, potassium pyrosulfite, sodium acid hexametaphosphate, potassium acid hexametaphosphate, sodium acid pyrophosphate, potassium acid pyrophosphate, sodium pyrophosphate, potassium ... Examples of suitable acids include solid acids such as sulfamic acid, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid, phthalic acid, isophthalic acid, terephthalic acid, glutamic acid, aspartic acid, glycolic acid, malic acid, tartaric acid, citric acid, lactic acid, hydroxyacrylic acid, α-hydroxybutyric acid, glyceric acid, tartronic acid, salicylic acid, gallic acid, tropic acid, ascorbic acid, and gluconic acid; and liquid acids such as hydrochloric acid and sulfuric acid. These acids may be used singly or in combination of two or more.

[0030] The content of the acid in the chlorine dioxide generating composition may be appropriately set depending on the shape of the chlorine dioxide generating composition, the manner in which chlorine dioxide is released, the installation site, etc., but it is desirable that the content be equal to or greater than the minimum amount required to react with the total amount of chlorite, specifically 0.01 to 15% by weight, preferably 1 to 10% by weight.

[0031] In the chlorine dioxide generating composition, as long as it contains the chlorite and the acid as the chlorine dioxide generation source, chlorine dioxide can be generated by absorbing water vapor in the air or by using flash water in the case of an embodiment in which the composition is diluted with flash water, thereby causing the chlorite and the acid to react with each other, even if water is not blended. However, from the viewpoint of efficiently generating chlorine dioxide, it is desirable that the chlorine dioxide generating composition contains water.

[0032] When water is contained in the chlorine dioxide generating composition, the content of water may be appropriately set depending on the form of the pharmaceutical composition of Aspect 2, and may be, for example, 30 to 99.69 wt %, preferably 70 to 97 wt %.

[0033] When the chlorine dioxide-generating composition contains water, the chlorine dioxide-generating composition may be in the form of an aqueous solution, or the chlorine dioxide-generating composition may be in the form of a gel and water may be retained in the gel, or a water-retaining base that retains water may be contained in the composition.

[0034] When forming a gel and retaining moisture in the gel, the type of gelling agent used for gelation is not particularly limited, and examples include components derived from brown algae, green algae, or red algae, such as alginic acid, agar, carrageenan, and fucoidan; polysaccharides such as Byakko extract, pectin, locust bean gum, and aloe polysaccharide; gums such as xanthan gum, tragacanth gum, and guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, and acrylic acid / methacrylic acid copolymer; polyglutamic acid and its derivatives; sugar compounds mainly consisting of glucosyltrehalose and hydrolyzed hydrogenated starch; and various water-absorbing resins such as starch-based, cellulose-based, and synthetic polymer-based.

[0035] When a gelling agent is contained in the chlorine dioxide generating composition, the content thereof is not particularly limited, but may be, for example, 0.2 to 25% by weight, and preferably 1 to 10% by weight.

[0036] When a moisture-retaining base that retains moisture is added, the type of moisture-retaining base to be used is not particularly limited as long as it has the property of being able to retain water, and examples include porous substances such as diatomaceous earth, zeolite, kaolin, perlite, bentonite, charcoal, etc. These moisture-retaining bases may be used alone or in combination of two or more.

[0037] When the chlorine dioxide generating composition contains a moisture-retaining base, the content is not particularly limited, but may be, for example, 0.2 to 25% by weight, preferably 1 to 10% by weight.

[0038] Furthermore, when the chlorine dioxide generating composition contains a moisture-retaining base that retains moisture, it may further contain a deliquescent solid agent as necessary. When moisture is retained in the moisture-retaining base, the water content in the chlorine dioxide generating composition becomes relatively low, which may slow down the rate of chlorine dioxide generation, but by further containing a deliquescent solid agent, it becomes possible to promote the generation of chlorine dioxide. The type of deliquescent solid agent is not particularly limited, and examples include aluminum chloride, calcium chloride, magnesium chloride, potassium monohydrogen phosphate, glycerin, etc. These deliquescent solid agents can be used alone. Alternatively, two or more of them may be used in combination.

[0039] When a deliquescent solid agent is contained in the chlorine dioxide generating composition, the content thereof is not particularly limited, but may be, for example, 0.1 to 30% by weight, and preferably 1 to 20% by weight.

[0040] Furthermore, when the chlorine dioxide generating composition contains water, the water in the chlorine dioxide generating composition may contain chlorine dioxide dissolved therein. By containing dissolved chlorine dioxide in this manner, it becomes possible to release chlorine dioxide more efficiently.

[0041] When the chlorine dioxide generating composition contains dissolved chlorine dioxide, the content of chlorine dioxide may be appropriately set depending on the content of water, etc., and may be, for example, 10 ppm to 10,000 ppm, preferably 50 to 6,000 ppm.

[0042] [Other ingredients] In addition to the components described above, the pharmaceutical composition used in the present invention may contain water, organic solvents, enzymes, disinfectants, chelating agents, colorants, pigments, emulsifiers, solubilizers, bulking agents, solubility regulators, bleaching agents, water repellents, hydrophilic agents, fillers, pH adjusters, buffers, antifoaming agents, excipients, etc. The contents of these components may be appropriately determined depending on the form of the pharmaceutical composition, the types of components used, etc.

[0043] [shape] The form of the pharmaceutical composition used in the present invention may be appropriately determined depending on its composition, the method of releasing the pharmaceutical ingredients, etc., and examples thereof include liquid, gel, paste, tablet, powder, granule, etc.

[0044] [Method of placing pharmaceutical composition and method of releasing pharmaceutical ingredients] In the toilet sanitary product of the present invention, the medicinal composition is placed on the bowl side of the toilet lid. By placing the medicinal composition on the bowl side of the toilet lid in this way, when the toilet is not in use (i.e., when the toilet lid is closed), the medicinal component is released into the space formed by the toilet lid and bowl, allowing the medicinal component to spread over the surface of the bowl, thereby achieving a sanitary effect on the bowl.

[0045] The toilet sanitary product of the present invention can be used for Western-style toilets, Japanese-style toilets, toilets for converting Japanese-style toilets to Western-style toilets easily, toilets with toilet seats attached, portable toilets, etc., but is preferably used for Western-style toilets. In the case of Japanese-style toilets, the toilet lid corresponds to the toilet cover, and the bowl corresponds to the toilet container.

[0046] Figures 1 and 2 show schematic diagrams of an embodiment in which a pharmaceutical composition 1 is placed on the bowl 3 side of a toilet lid 2 of a Western-style toilet. In Figure 1, the toilet lid 2 of the Western-style toilet is in an open position, while in Figure 2, the toilet lid 2 of the Western-style toilet is in a closed position. For the sake of convenience, the flow path of flush water from the water storage tank to the bowl is omitted in Figures 1 and 2.

[0047] In the present invention, "releasing a drug component from a drug composition" includes both an embodiment in which only the drug component is released from the drug composition and an embodiment in which other components (base, additives) are released together with the drug component.

[0048] In the toilet sanitary product of the present invention, the method for releasing the medicinal component from the medicinal composition is not particularly limited, as long as the medicinal component can be released into the internal space of the toilet bowl (the space formed by the toilet lid and the bowl, etc.) formed when the toilet lid is closed. For example, when a volatile medicinal component is used as the medicinal component, the medicinal component may be released by volatilizing (evaporating) the volatile medicinal component. Alternatively, the medicinal component may be released by spraying or dripping the medicinal composition. When a volatile medicinal component is released by volatilization, the medicinal composition used may be in any form, such as a liquid, gel, paste, tablet, powder, or granule. When the medicinal component is released by spraying or dripping, the medicinal composition used is preferably in liquid form.

[0049] Among these release methods, from the viewpoint of spreading the medicinal component over the entire surface of the bowl portion and more effectively imparting the sanitizing effect of the medicinal component, a preferred method is to use a volatile medicinal component as the medicinal component and allow the volatile medicinal component to volatilize.

[0050] When releasing a volatile drug component from a drug composition by evaporation, the volatile drug component may be forcibly released using physical means such as heat or ultrasound, but from the standpoint of ease of use and low cost, it is preferable to release the volatile drug component by natural evaporation.

[0051] When the drug component is released from the drug composition by spraying, the drug component may be released, for example, through a spray nozzle. When a volatile drug is released from the drug composition by dripping, the drug component may be released, for example, by gravity dripping or dripping using a mechanical means such as a pump.

[0052] The amount of chemical component released by the toilet bowl sanitary product of the present invention may be adjusted appropriately depending on the type of chemical component used. For example, if the chemical component is chlorine dioxide, which is released by vaporization to provide cleaning, antibacterial, and deodorizing effects, it is desirable to set the chlorine dioxide gas concentration in the internal space of the toilet bowl (the space formed by the toilet lid and bowl, etc.) formed when the toilet lid is closed for 12 hours to 0.01 ppm or more, preferably 0.01 to 100 ppm, more preferably 0.02 to 10 ppm, and particularly preferably 0.1 to 1 ppm. By controlling the chlorine dioxide gas concentration in the space formed by the toilet lid and bowl to be within the above range, it is possible to provide even more excellent cleaning effects (stain removal and antifouling effects). The amount of chlorine dioxide gas generated can be controlled by appropriately adjusting the content of chlorine dioxide contained in the chemical composition and / or the composition and content of the chlorine dioxide generating source.

[0053] [container] In the toilet sanitary product of the present invention, the pharmaceutical composition is placed in a container and placed on the bowl side of the toilet lid for use, but if the pharmaceutical composition is in the form of a sticky gel, the pharmaceutical composition may be adsorbed directly to the installation site without being placed in a container.

[0054] Specifically, the container for containing the pharmaceutical composition may have a container having a storage section for storing the pharmaceutical composition and a release section for releasing the pharmaceutical component from the pharmaceutical composition to the outside of the container. The container may be provided with a fixing section such as an adhesive or a suction cup for fixing the container to the toilet lid or the like. Containers used for each method of releasing the pharmaceutical component will be described below.

[0055] (Container that releases volatile pharmaceutical ingredients by volatilization) When using a pharmaceutical composition containing a volatile pharmaceutical component, one embodiment of a container for storing the pharmaceutical composition is a container having a storage section for storing the pharmaceutical composition and a release section consisting of a permeable film (volatile pharmaceutical component permeable film) through which the volatile pharmaceutical component can pass.

[0056] The volatile drug component-permeable film used as the release portion may be a so-called fragrance-permeable film, which is disclosed in International Publication No. 98 / 23304, Japanese Patent Application Laid-Open No. 6-219479, U.S. Patent No. 5,518,790, and is publicly known. The constituent material of the volatile drug component-permeable film is not particularly limited, but examples include polyethylene, polypropylene, ethylene-vinyl acetate copolymer, ethylene ethyl acrylate, paper, and mixtures thereof. Among these, linear low-density polyethylene (LLDPE) is preferred. The volatile drug component-permeable film used as the release portion may be a single-layer film made of one material, or a multi-layer film in which two or more layers made of the same or different materials are laminated.

[0057] A container having a release section made of a volatile pharmaceutical component-permeable film may be composed solely of a volatile pharmaceutical component-permeable film, or may be composed of a combination of a volatile pharmaceutical component-permeable film and a volatile pharmaceutical component-impermeable member. In the present invention, a volatile pharmaceutical component-impermeable member refers to a member that does not allow the permeation of not only the pharmaceutical composition but also the volatile pharmaceutical component. Various types of volatile pharmaceutical component-impermeable members are known, including glass, polyvinylidene chloride, polyethylene terephthalate, ethylene vinyl acetate copolymer, aluminum, etc., and these can be appropriately selected and used. The volatile pharmaceutical component-impermeable member can take various forms, such as a film, sheet, bag, or container, as long as it can be combined with the volatile pharmaceutical component-permeable film to form a container capable of enclosing the pharmaceutical composition.

[0058] A container having a release section made of a film permeable to volatile drug components may be directly provided with a fixing section such as an adhesive or suction cup for fixing to a toilet lid or the like, or the container may be supported on a removable support, and a fixing section for fixing to a toilet lid or the like may be provided on the support.

[0059] A container having a release portion made of a film permeable to volatile drug components can be applied to drug compositions of any shape, but is particularly suitable for use as a container for storing liquid or gel drug compositions.

[0060] Furthermore, for example, when using a pharmaceutical composition containing a volatile pharmaceutical component and having a shape-retaining form (such as a gel, tablet, granule, or powder), a container having a release portion made of nonwoven fabric may be used. A container having a release portion made of nonwoven fabric may be formed into a container shape (bag-like) using only nonwoven fabric, or may be constructed by combining nonwoven fabric with a volatile pharmaceutical component-impermeable member. The material, shape, etc. of the volatile pharmaceutical component-impermeable member are as described above.

[0061] A container having a release section made of nonwoven fabric may be directly provided with a fixing section such as an adhesive or suction cup for fixing to a toilet lid or the like, or the container may be supported on a removable support, and a fixing section for fixing to a toilet lid or the like may be provided on the support.

[0062] Furthermore, for example, when using a pharmaceutical composition containing a volatile pharmaceutical component and having a shape-retaining form (gel, tablet, granule, powder, etc.), a container may be used that has a storage section that can maintain the pharmaceutical composition in a fixed state and an opening (release section) for releasing the volatile pharmaceutical component that volatilizes from the pharmaceutical composition out of the container.

[0063] Furthermore, when a pharmaceutical composition containing a volatile pharmaceutical component is used and the volatile pharmaceutical component is forcibly released using physical means such as heat or ultrasound, the container to be used should have, in addition to the storage section and the release section, physical means for applying heat, ultrasound, etc., and a device for operating the physical means. It is sufficient that the device is provided with a power supply source for operating the device.

[0064] (Container that sprays and releases pharmaceutical ingredients) When the drug component is to be released by spraying from the drug composition, a container having a storage section for storing the drug composition and a spray nozzle (release section) for spraying the drug composition supplied from the storage section and releasing it outside the container may be used. The container may also be equipped with a power supply source and the like necessary for spraying the drug composition from the spray nozzle.

[0065] (Container that releases drug ingredients dropwise) When the drug component is released from the drug composition by dripping, a container having a storage section for storing the drug composition and a pore section (release section) for dripping the drug composition supplied from the storage section and releasing it outside the container may be used. When the drug composition is released by dripping using a mechanical means such as a pump, the container may be provided with a power supply source or the like required to operate the mechanical means. [Example]

[0066] The present invention will be described in detail below based on examples, but the present invention is not limited to these.

[0067] Test Example 1: Evaluation of fecal removal effect A gel-like pharmaceutical composition having the composition shown in Table 1 was prepared, and the following tests were carried out using a mixture of salad oil and carbon black as model fecal soiling in a salad oil:carbon black mass ratio of 100:2.

[0068] 30 g of each pharmaceutical composition was placed in a container having a storage section and an opening communicating from the storage section to the outside of the container. 3 g of model dirt was placed in the bowl of a toilet bowl with an openable toilet lid [a water tank manufactured by TOTO (model number: S721) and a toilet bowl manufactured by TOTO (model number: C720)], with a height of approximately 200 cm 2The gel-type cleansing agent was applied so that the amount of water in the container was 100 ml. Next, each gel-type cleansing agent was attached to the bowl side of the toilet lid, and the toilet was left for 12 hours with the toilet lid closed. After that, 100 ml of air was aspirated from the space inside the toilet bowl (the space formed by the toilet lid, bowl, etc.) with a syringe, and a chlorine dioxide gas detector tube (No. 23M (measurement range 0.1-10 ppm) or No. 23L (measurement range 0.025-1.2 ppm) (both manufactured by Gastec Corporation)) was inserted to measure the chlorine dioxide gas concentration. After leaving the toilet for 12 hours, approximately 13 L of water was flushed out, and the amount of remaining model dirt was visually determined. The dirt removal effect was evaluated according to the following criteria. <Criteria for determining dirt removal effectiveness> ⊚: The remaining rate of model dirt is less than 5%. ○: The remaining rate of model dirt is 5% or more and less than 20%. △: The remaining rate of model dirt is 20% or more and less than 50%. ×: The remaining rate of model dirt is 50% or more.

[0069] The results are shown in Table 1. As a result, it was confirmed that by placing a pharmaceutical composition containing a chlorine dioxide source on the toilet lid, chlorine dioxide gas can be released into the space inside the toilet bowl, thereby achieving the effect of removing dirt from the bowl of the toilet.

[0070] [Table 1]

[0071] Test Example 2: Evaluation of feces and blackhead removal effect and antifouling effect (field test) The following field test was conducted using the pharmaceutical compositions prepared in Test Example 1. Each pharmaceutical composition contained in a container was attached to the bowl side of the toilet lid of a household toilet for a four-person family. The container used was the same as in Test Example 1. The household toilet was used for seven days without cleaning. When the toilet was not in use, the toilet lid was kept closed. Furthermore, a household toilet for a four-person family is usually used 15 to 25 times per day. After seven days of use, the toilet was visually inspected for the presence or absence of fecal stains and blackening, and the effectiveness of removing fecal stains and blackening was evaluated according to the following evaluation criteria. <Criteria for determining dirt removal effectiveness> ⊚: No fecal stains or black spots were observed. ○: Slight fecal stains or black stains are observed. △: Fecal stains or black stains are slightly observed. ×: Significant fecal stains or black stains are observed.

[0072] The results are shown in Table 2. As a result, by placing a gel-type detergent containing a chlorine dioxide source on the toilet lid, the adhesion of fecal stains and black stains was sufficiently suppressed even when the toilet was used for seven days without cleaning, and it was confirmed that the release of chlorine dioxide gas into the space inside the toilet bowl provides excellent stain removal and anti-fouling effects.

[0073] [Table 2]

[0074] Reference Example 1: Evaluation of the effect of preventing darkening Gel-type pharmaceutical compositions having the compositions shown in Table 3 were prepared, and 10 g of each pharmaceutical composition was used to evaluate the effectiveness in preventing the occurrence of blackening. Potato dextrose agar medium was prepared in a plastic petri dish with a diameter of 8.7 cm, and 1 × 10 Cladosporium halotolerans (NBRC111839) (causing bacteria of blackening) was added. 8100 μl of a bacterial solution adjusted to a cell / ml concentration was applied. Next, the bacteria-applied petri dish (with the lid open) and the pharmaceutical composition contained in the container were placed in a lidded plastic case (volume 25 cm × 15 cm × 10 cm), the plastic case was sealed, and the case was left standing at 22.5°C for 5 days. The container used was the same as in Test Example 1 above. Thereafter, the state of bacterial growth on the plastic petri dish was visually confirmed, and the effect of preventing blackening was evaluated according to the following evaluation criteria. After the test was completed (after leaving it standing for 5 days), the chlorine dioxide concentration in the case was measured by slightly opening the lid of the case to draw 100 ml of air with a syringe through a gap, and the syringe was connected to a chlorine dioxide gas detector tube similar to that in Test Example 1. <Criteria for determining effectiveness in preventing dark spots> ○: No bacterial colonies were observed on the petri dish. △: The number of bacterial colonies observed on the petri dish was 10 or less. ×: The number of bacterial colonies observed on the petri dish is 11 or more and 100 or less. ××: Numerous bacterial colonies were observed on the petri dish.

[0075] The results are shown in Table 3. As a result, it was confirmed that the proliferation of bacteria that cause blackening can be effectively inhibited by releasing chlorine dioxide gas using a pharmaceutical composition containing a chlorine dioxide source.

[0076] [Table 3] [Explanation of symbols]

[0077] 1 Sanitary products for toilet bowls 2 Toilet lid 3 Bowl section 4 water

Claims

1. A toilet sanitary product for use in a toilet having an openable toilet lid, a pharmaceutical composition that releases a pharmaceutical component; The pharmaceutical ingredient has a vapor pressure of 1×10 at 25° C. -7 A volatile pharmaceutical component having a viscosity of 100 Pa or more, A toilet sanitary product that is installed on the bowl side of the toilet lid.

2. 2. The toilet sanitary product according to claim 1, wherein the volatile chemical component is at least one selected from the group consisting of a cleaning component, an antibacterial component, a fragrance component, and a deodorizing component.

3. The toilet bowl hygiene product according to claim 1, wherein the volatile chemical component is a fragrance component.

4. The toilet bowl hygiene product according to any one of claims 1 to 3, wherein the medicinal composition contains a medicinal component and / or a source of the medicinal component.

5. The toilet sanitary product according to any one of claims 1 to 4, wherein the pharmaceutical composition is contained in a container having a storage section for storing the pharmaceutical composition and a release section for releasing the pharmaceutical component from the pharmaceutical composition outside the container.

Images